# 8-K filed: Obsidian Therapeutics, Inc.

> sec 8k · VERIFIED · 2026-08-03

Filed: 2026-08-03 AccNo: 0001193125-26-330810 Size: 5 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.01: Completion of Acquisition or Disposition of Assets Item 2.02: Results of Operations and Financial Condition Item 3.02: Unregistered Sales of Equity Securities Item 3.03: Material Modifications to Rights of Security Holders Item 4.01: Changes in Registrant's Certifying Accountant Item 5.01: Changes in Control of Registrant Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

- Company: Obsidian Therapeutics, Inc.
- Sector: therapeutics
- Primary source: https://www.sec.gov/Archives/edgar/data/2130606/000119312526330810/0001193125-26-330810-index.htm

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.